Yahoo! Finance Finance Home - Yahoo! - Help

Registrations | Pricings | Withdrawals | Performers | IPOs

Iroko Pharmaceuticals IncProposed Symbol - Nasdaq: IRKO

One Kew Place, 150 Rouse Boulevard
  Philadelphia, Pennsylvania 19112
Financial Links
· Recent News

IPO Information as of 28-Mar-17
Offering Information
Expected DateWITHDRAWN
Proposed Exchange/Ticker Nasdaq: IRKO
Security Type Ordinary Shares
Lead Underwriter Jefferies LLC William Blair & Co Canaccord Genuity
Days In Registration 43
Date Filed -
Form FiledF-1
(Year Ending December 2016)
Industry Manufacturing
Business Description Iroko Pharmaceuticals Inc, located in Philadelphia, Pennsylvania, is a specialty pharmaceutical company focused on the development and commercialization of novel nonsteroidal anti-inflammatory drug, or NSAID, therapeutics for patients with mild to moderate acute and chronic pain. Its late-stage product candidates are submicron diclofenac (Zorvolex), submicron indomethacin (Tiforbex), submicron meloxicam and submicron naproxen and are being developed for both acute pain (Zorvolex, Tiforbex) and osteoarthritis pain (Zorvolex, submicron meloxicam, submicron naproxen) indications in adult patients. The company was founded in 2012.
Revenue -
Net Income -
Shares Outstanding (post-offering) 31.75M
Contact -
Number of Employees 71
Original Filing Information

Shares Filed -
Secondary Shares Filed-
  · As a Percent -
Primary Shares Filed -
  · As a Percent -
Overallotment Shares Filed -
File Amount $145.0M
File Price Range - - -
File Mid Price -

Copyright © 2017 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
IPO information Copyright © 2017 Thomson Financial Securities Data (TFSD)
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Hoover's, Inc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.